[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-001", "question": "A 28-year-old male with a history of opioid use disorder presents with syncope. He admits to taking 'massive doses' of an over-the-counter anti-diarrheal medication to manage withdrawal symptoms. ECG shows sinus bradycardia at 45 bpm, a QTc interval of 680 ms, and intermittent broad-complex beats. He is hemodynamically stable but lethargic. Magnesium sulfate 2g IV is administered without change in the rhythm. Which of the following is the most appropriate next step in management?", "options": ["Option A: IV Amiodarone infusion", "Option B: IV Isoproterenol infusion", "Option C: IV Physostigmine", "Option D: Synchronized cardioversion", "Option E: IV Calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The patient has loperamide toxicity, which blocks cardiac sodium and potassium channels, causing QTc prolongation and wide-complex dysrhythmias. Unlike congenital Long QT (where isoproterenol is contraindicated), loperamide-induced TdP/QT prolongation is bradycardia-dependent; increasing the heart rate (chemical or electrical overdrive pacing) shortens the QT interval and prevents Torsades de Pointes. Amiodarone prolongs QT and is contraindicated.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Opioid use disorder; “massive doses” of OTC antidiarrheal (loperamide); syncope; sinus bradycardia 45 bpm; extreme QTc prolongation (680 ms) with intermittent broad-complex beats; no response to IV magnesium; hemodynamically stable but lethargic. This fits loperamide cardiotoxicity (Na+ and K+ channel blockade) with bradycardia‑dependent QT prolongation and risk for torsades. For drug‑induced, pause‑dependent QT prolongation with bradycardia, the next step after magnesium is increasing heart rate (chemical/electrical overdrive pacing); IV isoproterenol is appropriate in a stable patient.\\nChoice review: A (amiodarone) further prolongs QT and is contraindicated in torsades risk. C (physostigmine) is used for anticholinergic toxicity, not relevant here. D (synchronized cardioversion) is not indicated because the patient is currently stable and in sinus bradycardia, not unstable VT. E (calcium gluconate) is for hyperkalemia or Ca‑channel blocker toxicity, not primary therapy for loperamide‑induced QT prolongation.\\nMedical accuracy issues: Explanation and key are consistent with current understanding of loperamide toxicity and torsades management.\\nMinimal fix: Clarify that intermittent broad‑complex beats represent polymorphic VT/torsades risk to make the rationale for overdrive pacing even more explicit.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Opioid use disorder; “massive doses” of OTC antidiarrheal (loperamide); syncope; sinus bradycardia 45 bpm; extreme QTc prolongation (680 ms) with intermittent broad-complex beats; no response to IV magnesium; hemodynamically stable but lethargic. This fits loperamide cardiotoxicity (Na+ and K+ channel blockade) with bradycardia‑dependent QT prolongation and risk for torsades. For drug‑induced, pause‑dependent QT prolongation with bradycardia, the next step after magnesium is increasing heart rate (chemical/electrical overdrive pacing); IV isoproterenol is appropriate in a stable patient.\nChoice review: A (amiodarone) further prolongs QT and is contraindicated in torsades risk. C (physostigmine) is used for anticholinergic toxicity, not relevant here. D (synchronized cardioversion) is not indicated because the patient is currently stable and in sinus bradycardia, not unstable VT. E (calcium gluconate) is for hyperkalemia or Ca‑channel blocker toxicity, not primary therapy for loperamide‑induced QT prolongation.\nMedical accuracy issues: Explanation and key are consistent with current understanding of loperamide toxicity and torsades management.\nMinimal fix: Clarify that intermittent broad‑complex beats represent polymorphic VT/torsades risk to make the rationale for overdrive pacing even more explicit.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-002", "question": "A 4-month-old female presents with failure to thrive, hypotonia, and a history of pyridoxine-responsive seizures. Laboratory evaluation reveals hypercalcemia, hypercalciuria, and a suppressed parathyroid hormone (PTH) level. Skeletal survey demonstrates diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses. Serum alkaline phosphatase (ALP) is 15 IU/L (Reference: 150-420 IU/L). Which of the following is the definitive treatment for this condition?", "options": ["Option A: High-dose Vitamin D supplementation", "Option B: Recombinant human parathyroid hormone (Teriparatide)", "Option C: Asfotase alfa", "Option D: Pyridoxine (Vitamin B6) monotherapy", "Option E: Bisphosphonate therapy"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Hypophosphatasia (HPP), caused by a loss-of-function mutation in the ALPL gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Low ALP leads to accumulation of inorganic pyrophosphate (an inhibitor of bone mineralization) and pyridoxal-5'-phosphate (causing B6-dependent seizures due to lack of dephosphorylation). Asfotase alfa is the enzyme replacement therapy. Vitamin D and bisphosphonates are contraindicated as they may worsen hypercalcemia and inhibit mineralization further.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 4‑month-old infant with failure to thrive, hypotonia, pyridoxine‑responsive seizures, hypercalcemia, hypercalciuria, suppressed PTH, very low ALP, and radiographic diffuse demineralization with metaphyseal “moth‑eaten” lucencies. This classic constellation points to infantile hypophosphatasia due to tissue-nonspecific alkaline phosphatase deficiency. The only disease-specific, definitive therapy is enzyme replacement with asfotase alfa (choice C).\\nEvaluation of alternatives: High‑dose vitamin D (A) would not treat the enzymatic defect and may worsen hypercalcemia; bisphosphonates (E) further inhibit mineralization and are relatively contraindicated. Recombinant PTH/teriparatide (B) is not indicated and PTH is already suppressed from hypercalcemia. Pyridoxine alone (D) addresses seizures but not bone disease or underlying enzyme deficiency; not definitive.\\nMain logical issues: None—findings are highly specific and map uniquely to hypophosphatasia with known standard treatment.\\nMain medical accuracy issues: Explanation is consistent with current understanding of HPP pathophysiology and therapy; the note on vitamin D/bisphosphonates is appropriate, though in practice supportive measures are used adjunctively.\\nMinimal fix: Clarify in stem that patient has genetically confirmed hypophosphatasia to remove any residual diagnostic ambiguity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 4‑month-old infant with failure to thrive, hypotonia, pyridoxine‑responsive seizures, hypercalcemia, hypercalciuria, suppressed PTH, very low ALP, and radiographic diffuse demineralization with metaphyseal “moth‑eaten” lucencies. This classic constellation points to infantile hypophosphatasia due to tissue-nonspecific alkaline phosphatase deficiency. The only disease-specific, definitive therapy is enzyme replacement with asfotase alfa (choice C).\nEvaluation of alternatives: High‑dose vitamin D (A) would not treat the enzymatic defect and may worsen hypercalcemia; bisphosphonates (E) further inhibit mineralization and are relatively contraindicated. Recombinant PTH/teriparatide (B) is not indicated and PTH is already suppressed from hypercalcemia. Pyridoxine alone (D) addresses seizures but not bone disease or underlying enzyme deficiency; not definitive.\nMain logical issues: None—findings are highly specific and map uniquely to hypophosphatasia with known standard treatment.\nMain medical accuracy issues: Explanation is consistent with current understanding of HPP pathophysiology and therapy; the note on vitamin D/bisphosphonates is appropriate, though in practice supportive measures are used adjunctively.\nMinimal fix: Clarify in stem that patient has genetically confirmed hypophosphatasia to remove any residual diagnostic ambiguity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-003", "question": "A 68-year-old male presents with recurrent fevers, painful auricular chondritis, pulmonary infiltrates, and macrocytic anemia. He has been treated for 'refractory relapsing polychondritis' without success. Bone marrow biopsy reveals hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells. Which of the following is the most likely diagnosis?", "options": ["Option A: Myelodysplastic Syndrome (MDS) with excess blasts", "Option B: VEXAS syndrome", "Option C: Sweet syndrome", "Option D: Polyarteritis Nodosa", "Option E: Granulomatosis with Polyangiitis"], "answer": "B", "answer_index": 1, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in the UBA1 gene. It presents in older men with inflammatory features (chondritis, vasculitis, fevers) and hematologic abnormalities (macrocytic anemia). The pathognomonic finding is vacuoles in myeloid and erythroid precursors in the bone marrow.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Older man (68 years), recurrent fevers, painful auricular chondritis, pulmonary infiltrates, macrocytic anemia, refractoriness when treated as relapsing polychondritis, and bone marrow hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursors. These findings collectively are classic for VEXAS (Vacuoles, E1 enzyme, X‑linked, Autoinflammatory, Somatic) syndrome due to UBA1 mutation.\\nWhy alternatives are worse: MDS with excess blasts (A) could explain macrocytic anemia and marrow changes but not the characteristic systemic inflammatory/auricular chondritis constellation; vacuoles as described are specifically linked to VEXAS, not generic MDS with excess blasts. Sweet syndrome (C) causes neutrophilic dermatosis and fever but not auricular chondritis or characteristic marrow vacuoles. Polyarteritis nodosa (D) and granulomatosis with polyangiitis (E) can produce systemic inflammation and pulmonary/ENT findings, but neither explains the distinctive cytoplasmic vacuoles and macrocytic anemia pattern.\\nMain medical accuracy issues: None significant; description of VEXAS is current and accurate. Minimal fix: Option A could specify “without characteristic cytoplasmic vacuoles” in the stem’s differential discussion, but the item is already unambiguous.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Older man (68 years), recurrent fevers, painful auricular chondritis, pulmonary infiltrates, macrocytic anemia, refractoriness when treated as relapsing polychondritis, and bone marrow hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursors. These findings collectively are classic for VEXAS (Vacuoles, E1 enzyme, X‑linked, Autoinflammatory, Somatic) syndrome due to UBA1 mutation.\nWhy alternatives are worse: MDS with excess blasts (A) could explain macrocytic anemia and marrow changes but not the characteristic systemic inflammatory/auricular chondritis constellation; vacuoles as described are specifically linked to VEXAS, not generic MDS with excess blasts. Sweet syndrome (C) causes neutrophilic dermatosis and fever but not auricular chondritis or characteristic marrow vacuoles. Polyarteritis nodosa (D) and granulomatosis with polyangiitis (E) can produce systemic inflammation and pulmonary/ENT findings, but neither explains the distinctive cytoplasmic vacuoles and macrocytic anemia pattern.\nMain medical accuracy issues: None significant; description of VEXAS is current and accurate. Minimal fix: Option A could specify “without characteristic cytoplasmic vacuoles” in the stem’s differential discussion, but the item is already unambiguous.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-004", "question": "A 55-year-old female with chronic malnutrition and a history of chronic acetaminophen use for osteoarthritis presents with altered mental status. Arterial blood gas shows pH 7.28, pCO2 28 mmHg, HCO3 12 mEq/L. The anion gap is 24. Lactate is 0.9 mmol/L, serum ketones are negative, and creatinine is 1.1 mg/dL. Toxic alcohol screen is negative. Which of the following is the most appropriate therapeutic intervention?", "options": ["Option A: IV Fomepizole", "Option B: IV Sodium Bicarbonate", "Option C: N-acetylcysteine", "Option D: Hemodialysis", "Option E: Thiamine and Dextrose"], "answer": "C", "answer_index": 2, "explanation": "This patient has high anion gap metabolic acidosis due to 5-oxoproline (pyroglutamic acid) accumulation. This occurs in the setting of glutathione depletion (malnutrition, acetaminophen use), which disrupts the gamma-glutamyl cycle. N-acetylcysteine replenishes glutathione stores, restoring the feedback loop and halting 5-oxoproline production. Fomepizole is for toxic alcohols, which were ruled out.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 55-year-old woman, chronic malnutrition, chronic acetaminophen use, high anion gap metabolic acidosis (pH 7.28, HCO3 12, anion gap 24), normal lactate, negative ketones, normal creatinine, negative toxic alcohol screen. These features point to high–anion gap metabolic acidosis from 5-oxoproline (pyroglutamic acidosis) due to glutathione depletion in the gamma‑glutamyl cycle, classically associated with malnutrition and chronic acetaminophen.\\n\\nN-acetylcysteine is mechanistically appropriate as it replenishes glutathione and is reported therapy for 5-oxoproline acidosis; thus C is a defensible best answer. Other options: Fomepizole (A) is for toxic alcohols, which are ruled out. IV bicarbonate (B) is not first-line without more severe acidosis or hemodynamic instability. Hemodialysis (D) is for severe, refractory acidosis or dialyzable toxins, not indicated here with normal creatinine and modest acidosis. Thiamine/dextrose (E) target Wernicke’s/ethanol-related issues, not this mechanism.\\n\\nMain medical accuracy issues: Minor—pyroglutamic acidosis is rare and not universally recognized board content, but the pathophysiology and treatment given are correct. Minimal fix: Explicitly name 5-oxoproline acidosis or gamma‑glutamyl cycle disruption in the stem or explanation to solidify the teaching point and link to NAC therapy.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 55-year-old woman, chronic malnutrition, chronic acetaminophen use, high anion gap metabolic acidosis (pH 7.28, HCO3 12, anion gap 24), normal lactate, negative ketones, normal creatinine, negative toxic alcohol screen. These features point to high–anion gap metabolic acidosis from 5-oxoproline (pyroglutamic acidosis) due to glutathione depletion in the gamma‑glutamyl cycle, classically associated with malnutrition and chronic acetaminophen.\n\nN-acetylcysteine is mechanistically appropriate as it replenishes glutathione and is reported therapy for 5-oxoproline acidosis; thus C is a defensible best answer. Other options: Fomepizole (A) is for toxic alcohols, which are ruled out. IV bicarbonate (B) is not first-line without more severe acidosis or hemodynamic instability. Hemodialysis (D) is for severe, refractory acidosis or dialyzable toxins, not indicated here with normal creatinine and modest acidosis. Thiamine/dextrose (E) target Wernicke’s/ethanol-related issues, not this mechanism.\n\nMain medical accuracy issues: Minor—pyroglutamic acidosis is rare and not universally recognized board content, but the pathophysiology and treatment given are correct. Minimal fix: Explicitly name 5-oxoproline acidosis or gamma‑glutamyl cycle disruption in the stem or explanation to solidify the teaching point and link to NAC therapy.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 32-year-old woman, amenorrhea/galactorrhea, very large pituitary macroadenoma (4.5 cm) with cavernous sinus invasion, intact visual fields, modestly elevated prolactin (145 ng/mL) despite large tumor. For a true macroprolactinoma of that size, prolactin is usually markedly higher (often >200 and can be >1,000 ng/mL). This discordance strongly suggests the assay “hook effect,” in which very high prolactin causes falsely low readings, and the appropriate next step is to repeat prolactin on a diluted sample. That makes C the single best choice.\\nOther options: A) Transsphenoidal surgery is not first-line for prolactinomas and should not proceed before biochemical clarification. B) Radiosurgery is reserved for refractory/adjunctive cases, not initial step. D) Octreotide scintigraphy is for neuroendocrine tumors, not needed here. E) Inferior petrosal sinus sampling is for ACTH-dependent Cushing disease, not prolactinomas.\\nMedical accuracy: The explanation’s prolactin range (>1,000–10,000 ng/mL) is somewhat exaggerated but directionally correct and not dangerously misleading.\\nMinimal fix: Adjust explanation wording to “often >200 ng/mL and can exceed 1,000 ng/mL” to be more realistic, and explicitly mention that the purpose of dilution is to rule out hook effect before deciding on dopamine agonist vs surgery.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 32-year-old woman, amenorrhea/galactorrhea, very large pituitary macroadenoma (4.5 cm) with cavernous sinus invasion, intact visual fields, modestly elevated prolactin (145 ng/mL) despite large tumor. For a true macroprolactinoma of that size, prolactin is usually markedly higher (often >200 and can be >1,000 ng/mL). This discordance strongly suggests the assay “hook effect,” in which very high prolactin causes falsely low readings, and the appropriate next step is to repeat prolactin on a diluted sample. That makes C the single best choice.\nOther options: A) Transsphenoidal surgery is not first-line for prolactinomas and should not proceed before biochemical clarification. B) Radiosurgery is reserved for refractory/adjunctive cases, not initial step. D) Octreotide scintigraphy is for neuroendocrine tumors, not needed here. E) Inferior petrosal sinus sampling is for ACTH-dependent Cushing disease, not prolactinomas.\nMedical accuracy: The explanation’s prolactin range (>1,000–10,000 ng/mL) is somewhat exaggerated but directionally correct and not dangerously misleading.\nMinimal fix: Adjust explanation wording to “often >200 ng/mL and can exceed 1,000 ng/mL” to be more realistic, and explicitly mention that the purpose of dilution is to rule out hook effect before deciding on dopamine agonist vs surgery.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-006", "question": "A 60-year-old male with a history of radiation therapy for Hodgkin lymphoma presents with signs of cardiac tamponade. Pericardiocentesis is performed, draining 800 mL of bloody fluid. Following drainage, the intrapericardial pressure drops to 0 mmHg, but the right atrial pressure remains elevated at 18 mmHg with a prominent y-descent that was previously absent. Which of the following is the most likely diagnosis?", "options": ["Option A: Incomplete drainage of the effusion", "Option B: Effusive-constrictive pericarditis", "Option C: Right ventricular infarction", "Option D: Pulmonary embolism", "Option E: Flash pulmonary edema"], "answer": "B", "answer_index": 1, "explanation": "Effusive-constrictive pericarditis is characterized by concurrent tamponade and constriction. The visceral pericardium is thickened and constrictive. Initially, the effusion masks the constriction (tamponade physiology: blunted y-descent). After drainage, the tamponade resolves, but the underlying constriction becomes manifest (elevated RA pressure with prominent y-descent). Treatment requires visceral pericardiectomy.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Prior mediastinal radiation (risk factor for constrictive/effusive-constrictive pericarditis); presentation with tamponade requiring pericardiocentesis; drainage of large bloody effusion with intrapericardial pressure falling to 0 mmHg (tamponade physiology relieved); persistent elevation of right atrial pressure at 18 mmHg plus new prominent y‑descent. In pure tamponade, RA pressure should normalize and y‑descent remains blunted; in constriction, RA pressure stays elevated and y‑descent is prominent. Effusive‑constrictive pericarditis perfectly matches: effusion causing tamponade initially masks underlying constriction, which becomes evident after fluid removal.\\nOther options: Incomplete drainage (A) unlikely with intrapericardial pressure to 0 mmHg; RV infarction (C) and pulmonary embolism (D) do not explain initial tamponade physiology or radiation history, and have different hemodynamics; flash pulmonary edema (E) is a clinical state, not a specific hemodynamic pattern and not linked to these RA waveform changes.\\nMedical accuracy issues: None; pathophysiology and management described are standard.\\nMinimal fix: Clarify that pressures and RA waveform are measured by catheterization immediately before and after pericardiocentesis to make the hemodynamic context explicit, though this is already implied.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Prior mediastinal radiation (risk factor for constrictive/effusive-constrictive pericarditis); presentation with tamponade requiring pericardiocentesis; drainage of large bloody effusion with intrapericardial pressure falling to 0 mmHg (tamponade physiology relieved); persistent elevation of right atrial pressure at 18 mmHg plus new prominent y‑descent. In pure tamponade, RA pressure should normalize and y‑descent remains blunted; in constriction, RA pressure stays elevated and y‑descent is prominent. Effusive‑constrictive pericarditis perfectly matches: effusion causing tamponade initially masks underlying constriction, which becomes evident after fluid removal.\nOther options: Incomplete drainage (A) unlikely with intrapericardial pressure to 0 mmHg; RV infarction (C) and pulmonary embolism (D) do not explain initial tamponade physiology or radiation history, and have different hemodynamics; flash pulmonary edema (E) is a clinical state, not a specific hemodynamic pattern and not linked to these RA waveform changes.\nMedical accuracy issues: None; pathophysiology and management described are standard.\nMinimal fix: Clarify that pressures and RA waveform are measured by catheterization immediately before and after pericardiocentesis to make the hemodynamic context explicit, though this is already implied.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-007", "question": "A 65-year-old male is admitted to the ICU for sedation and mechanical ventilation. On day 3 of a continuous propofol infusion, he develops new Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3. Labs reveal severe metabolic acidosis (pH 7.18), Lactate 9 mmol/L, and CK 8,000 U/L. Echocardiogram shows new global hypokinesis. Which of the following is the most likely diagnosis?", "options": ["Option A: Acute Anterior ST-Elevation MI", "Option B: Massive Pulmonary Embolism", "Option C: Propofol Infusion Syndrome", "Option D: Brugada Syndrome unmasked by fever", "Option E: Septic Cardiomyopathy"], "answer": "C", "answer_index": 2, "explanation": "Propofol Infusion Syndrome (PRIS) is a rare but lethal complication of high-dose/long-duration propofol. It causes mitochondrial failure leading to rhabdomyolysis, metabolic acidosis, heart failure, and characteristic ECG changes (often Brugada-like pattern: RBBB with coved ST elevation). Immediate cessation of propofol and supportive care is required.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: ICU patient on continuous propofol infusion for several days; severe high–anion gap metabolic acidosis (pH 7.18, lactate 9), very high CK (8,000) suggesting rhabdomyolysis, new global hypokinesis on echo (acute cardiomyopathy), and new RBBB with coved ST-segment elevation in V1–V3 (Brugada-like ECG pattern). This classic cluster strongly indicates propofol infusion syndrome (PRIS).\\nAlternative options: Acute anterior STEMI (A) would explain ST elevation but typically with regional wall-motion abnormality, not global hypokinesis, and would not explain profound lactate elevation and rhabdomyolysis. Massive PE (B) would show RV strain patterns and hypotension; global LV hypokinesis, rhabdomyolysis, and very high lactate are not characteristic. Brugada syndrome unmasked by fever (D) could explain the ECG but not the profound metabolic acidosis, lactate, rhabdomyolysis, and global LV dysfunction. Septic cardiomyopathy (E) could cause global hypokinesis and lactic acidosis, but the tight temporal association with propofol and Brugada-like ECG pattern make PRIS clearly superior.\\nMain medical accuracy issues: None significant; description of PRIS and its features is accurate and current.\\nMinimal fix: Option labels could omit “Option A/B…” for cleaner exam style, but this is cosmetic, not required for validity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: ICU patient on continuous propofol infusion for several days; severe high–anion gap metabolic acidosis (pH 7.18, lactate 9), very high CK (8,000) suggesting rhabdomyolysis, new global hypokinesis on echo (acute cardiomyopathy), and new RBBB with coved ST-segment elevation in V1–V3 (Brugada-like ECG pattern). This classic cluster strongly indicates propofol infusion syndrome (PRIS).\nAlternative options: Acute anterior STEMI (A) would explain ST elevation but typically with regional wall-motion abnormality, not global hypokinesis, and would not explain profound lactate elevation and rhabdomyolysis. Massive PE (B) would show RV strain patterns and hypotension; global LV hypokinesis, rhabdomyolysis, and very high lactate are not characteristic. Brugada syndrome unmasked by fever (D) could explain the ECG but not the profound metabolic acidosis, lactate, rhabdomyolysis, and global LV dysfunction. Septic cardiomyopathy (E) could cause global hypokinesis and lactic acidosis, but the tight temporal association with propofol and Brugada-like ECG pattern make PRIS clearly superior.\nMain medical accuracy issues: None significant; description of PRIS and its features is accurate and current.\nMinimal fix: Option labels could omit “Option A/B…” for cleaner exam style, but this is cosmetic, not required for validity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-008", "question": "A 58-year-old male with dyslipidemia develops proximal muscle weakness and myalgias. His CK is 8,500 U/L. Atorvastatin is discontinued. Two months later, his weakness has progressed, and CK remains elevated at 9,200 U/L. Muscle biopsy shows necrotizing myopathy with minimal inflammation. Testing for anti-HMGCR antibodies is positive. Which of the following is the most appropriate management?", "options": ["Option A: Switch to Rosuvastatin", "Option B: Initiate Coenzyme Q10 supplementation", "Option C: Initiate IVIG and/or systemic immunosuppression", "Option D: Observation for spontaneous resolution", "Option E: Dantrolene sodium"], "answer": "C", "answer_index": 2, "explanation": "This patient has Statin-Associated Autoimmune Myopathy (SAAM), specifically anti-HMGCR positive necrotizing myopathy. Unlike self-limited statin myotoxicity, this is an autoimmune process that progresses despite statin cessation. It requires aggressive immunosuppression (steroids, IVIG, Rituximab, or Methotrexate) to prevent permanent muscle loss.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Longstanding dyslipidemia treated with atorvastatin; severe proximal weakness and marked CK elevation; progression of symptoms and persistent CK elevation despite statin discontinuation for 2 months; muscle biopsy with necrotizing myopathy and minimal inflammation; positive anti-HMGCR antibodies. These features clearly indicate statin-associated autoimmune necrotizing myopathy rather than self-limited toxic statin myopathy.\\nOption C (IVIG and/or systemic immunosuppression) is appropriate because SAAM is an autoimmune process that typically requires high-dose steroids, IVIG, and/or other steroid-sparing immunosuppressants to control disease and prevent permanent muscle damage.\\nOther options: A (switch to rosuvastatin) contradicts ongoing autoimmune myopathy due to statins and would worsen/maintain the trigger. B (CoQ10) may help mild statin myalgias, but is inadequate for autoimmune necrotizing myopathy. D (observation) is unsafe because disease is progressing despite drug withdrawal. E (dantrolene) is used for malignant hyperthermia and some spasticity, not for inflammatory/autoimmune myopathy.\\nMain medical accuracy issues: None significant; pathophysiology and management are current and accurate.\\nMinimal fix: Clarify that other secondary causes of myopathy (e.g., thyroid, drugs) have been excluded, though this is not essential for answer discrimination here.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Longstanding dyslipidemia treated with atorvastatin; severe proximal weakness and marked CK elevation; progression of symptoms and persistent CK elevation despite statin discontinuation for 2 months; muscle biopsy with necrotizing myopathy and minimal inflammation; positive anti-HMGCR antibodies. These features clearly indicate statin-associated autoimmune necrotizing myopathy rather than self-limited toxic statin myopathy.\nOption C (IVIG and/or systemic immunosuppression) is appropriate because SAAM is an autoimmune process that typically requires high-dose steroids, IVIG, and/or other steroid-sparing immunosuppressants to control disease and prevent permanent muscle damage.\nOther options: A (switch to rosuvastatin) contradicts ongoing autoimmune myopathy due to statins and would worsen/maintain the trigger. B (CoQ10) may help mild statin myalgias, but is inadequate for autoimmune necrotizing myopathy. D (observation) is unsafe because disease is progressing despite drug withdrawal. E (dantrolene) is used for malignant hyperthermia and some spasticity, not for inflammatory/autoimmune myopathy.\nMain medical accuracy issues: None significant; pathophysiology and management are current and accurate.\nMinimal fix: Clarify that other secondary causes of myopathy (e.g., thyroid, drugs) have been excluded, though this is not essential for answer discrimination here.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-009", "question": "A 2-week-old XX infant presents with ambiguous genitalia (virilization). Vital signs reveal a blood pressure of 96/60 mmHg (hypertensive for age). Laboratory evaluation shows Sodium 136 mEq/L and Potassium 2.9 mEq/L. 17-hydroxyprogesterone is elevated. Which of the following enzyme deficiencies is the most likely cause?", "options": ["Option A: 21-hydroxylase deficiency", "Option B: 11-beta-hydroxylase deficiency", "Option C: 17-alpha-hydroxylase deficiency", "Option D: 3-beta-hydroxysteroid dehydrogenase deficiency", "Option E: P450 oxidoreductase deficiency"], "answer": "B", "answer_index": 1, "explanation": "Congenital Adrenal Hyperplasia due to 11-beta-hydroxylase deficiency blocks cortisol synthesis, shunting precursors to androgens (causing virilization in females) and accumulating 11-deoxycorticosterone (DOC). DOC is a potent mineralocorticoid, leading to salt retention, hypertension, and hypokalemia. This distinguishes it from the more common 21-hydroxylase deficiency, which causes salt-wasting (hypotension, hyperkalemia).", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 2-week-old XX infant with virilization (ambiguous genitalia), elevated 17-hydroxyprogesterone, hypertension (96/60, high for age), and hypokalemia (K+ 2.9) with normal sodium. These findings indicate congenital adrenal hyperplasia with excess mineralocorticoid activity (hypertension, hypokalemia) plus androgen excess (virilization). Among CAH types, 11-β-hydroxylase deficiency causes accumulation of 11-deoxycorticosterone, a mineralocorticoid, producing hypertension and hypokalemia, while shunting steroid precursors to androgens, explaining virilization. This pattern contrasts with 21-hydroxylase deficiency, which typically causes salt-wasting, hypotension, and hyperkalemia, not seen here. 17-α-hydroxylase deficiency causes hypertension but sexual infantilism/undervirilization, not virilization. 3-β-hydroxysteroid dehydrogenase deficiency leads to decreased androgens and often salt-wasting, not hypertension and hypokalemia. P450 oxidoreductase deficiency presents with different patterns including skeletal anomalies and is not defined by this classic triad. No internal contradictions or missing critical data; age and sex assignment are adequate to support a unique best answer.\\nMain medical accuracy issues: None significant; explanation correctly distinguishes 11-β vs 21-hydroxylase CAH.\\nMinimal fix: None required; item is already unambiguous and accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 2-week-old XX infant with virilization (ambiguous genitalia), elevated 17-hydroxyprogesterone, hypertension (96/60, high for age), and hypokalemia (K+ 2.9) with normal sodium. These findings indicate congenital adrenal hyperplasia with excess mineralocorticoid activity (hypertension, hypokalemia) plus androgen excess (virilization). Among CAH types, 11-β-hydroxylase deficiency causes accumulation of 11-deoxycorticosterone, a mineralocorticoid, producing hypertension and hypokalemia, while shunting steroid precursors to androgens, explaining virilization. This pattern contrasts with 21-hydroxylase deficiency, which typically causes salt-wasting, hypotension, and hyperkalemia, not seen here. 17-α-hydroxylase deficiency causes hypertension but sexual infantilism/undervirilization, not virilization. 3-β-hydroxysteroid dehydrogenase deficiency leads to decreased androgens and often salt-wasting, not hypertension and hypokalemia. P450 oxidoreductase deficiency presents with different patterns including skeletal anomalies and is not defined by this classic triad. No internal contradictions or missing critical data; age and sex assignment are adequate to support a unique best answer.\nMain medical accuracy issues: None significant; explanation correctly distinguishes 11-β vs 21-hydroxylase CAH.\nMinimal fix: None required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-010", "question": "A 45-year-old male on chronic amiodarone therapy for atrial fibrillation presents with weight loss and palpitations. TSH is <0.01 mIU/L and Free T4 is elevated. He has no neck pain. Thyroid ultrasound with color flow Doppler reveals an absence of vascularity within the thyroid parenchyma. Which of the following is the most appropriate initial treatment?", "options": ["Option A: Methimazole", "Option B: Propylthiouracil", "Option C: Prednisone", "Option D: Radioactive Iodine ablation", "Option E: Potassium Perchlorate"], "answer": "C", "answer_index": 2, "explanation": "This is Type 2 Amiodarone-Induced Thyrotoxicosis (AIT), which is a destructive thyroiditis caused by direct cytotoxic effects of the drug. The key differentiator from Type 1 AIT (Jod-Basedow/iodine-induced synthesis) is the Doppler flow: Type 1 has increased vascularity, while Type 2 has absent vascularity. Type 2 is treated with high-dose glucocorticoids. Thionamides (Methimazole) are ineffective for destructive thyroiditis.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Chronic amiodarone use; new weight loss and palpitations; suppressed TSH with elevated free T4 (thyrotoxicosis); no neck pain; Doppler ultrasound shows *absence* of thyroid vascularity. These features are classic for type 2 amiodarone-induced thyrotoxicosis (destructive thyroiditis), which is treated initially with glucocorticoids.\\nThe keyed answer, prednisone (C), is appropriate: type 2 AIT is a destructive, inflammatory process with release of preformed hormone, so steroids are first-line to reduce inflammation and hormone release. Thionamides (A, B) target hormone synthesis and are ineffective for pure destructive thyroiditis. Radioactive iodine (D) is not ideal in amiodarone patients because of iodine load and because uptake is typically low in type 2 AIT. Potassium perchlorate (E) may be used occasionally in type 1 AIT to block iodine uptake, not in type 2.\\nNo major logical or medical inaccuracies are present; the Doppler finding is a strong discriminator. \\nMinimal fix: Specify “start high-dose oral prednisone (e.g., 40–60 mg/day)” in the explanation to clarify dosing, but the stem and choices already allow an unambiguous, accurate answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Chronic amiodarone use; new weight loss and palpitations; suppressed TSH with elevated free T4 (thyrotoxicosis); no neck pain; Doppler ultrasound shows *absence* of thyroid vascularity. These features are classic for type 2 amiodarone-induced thyrotoxicosis (destructive thyroiditis), which is treated initially with glucocorticoids.\nThe keyed answer, prednisone (C), is appropriate: type 2 AIT is a destructive, inflammatory process with release of preformed hormone, so steroids are first-line to reduce inflammation and hormone release. Thionamides (A, B) target hormone synthesis and are ineffective for pure destructive thyroiditis. Radioactive iodine (D) is not ideal in amiodarone patients because of iodine load and because uptake is typically low in type 2 AIT. Potassium perchlorate (E) may be used occasionally in type 1 AIT to block iodine uptake, not in type 2.\nNo major logical or medical inaccuracies are present; the Doppler finding is a strong discriminator. \nMinimal fix: Specify “start high-dose oral prednisone (e.g., 40–60 mg/day)” in the explanation to clarify dosing, but the stem and choices already allow an unambiguous, accurate answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]